Cubist Systematic Strategies’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-22,804
Closed -$1.98M 3603
2024
Q4
$1.75M Sell
22,804
-101,914
-82% -$7.12M 0.01% 1445
2024
Q3
$5.29M Buy
124,718
+48,017
+63% +$1.62M 0.03% 803
2024
Q2
$2M Buy
76,701
+65,312
+573% +$1.24M 0.01% 1330
2024
Q1
$104K Buy
+11,389
New +$68.4K ﹤0.01% 3254
2022
Q4
Sell
-554
Closed -$16K 4637
2022
Q3
$16K Sell
554
-270
-33% -$12.4K ﹤0.01% 4253
2022
Q2
$34K Sell
824
-5,796
-88% -$393K ﹤0.01% 4157
2022
Q1
$671K Sell
6,620
-1,288
-16% -$143K 0.01% 2337
2021
Q4
$1.16M Buy
7,908
+2,629
+50% +$587K 0.01% 1806
2021
Q3
$1.32M Buy
+5,279
New +$1.81M 0.02% 1310

Other funds holding WGS

Cubist Systematic Strategies's WGS Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of GeneDx Holdings (WGS) in Q1 2025, closing a stake of 22,804 shares — an estimated $1.98M sold.

Cubist Systematic Strategies first reported a position in WGS in Q3 2021 and held it in 9 quarters. The position peaked at $5.29M in Q3 2024. 225 funds tracked by Wall St. Rank hold WGS as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining GeneDx Holdings position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 22,804 GeneDx Holdings shares in Q1 2025, an estimated $1.98M.
  • Cubist Systematic Strategies first reported a position in GeneDx Holdings in Q3 2021 and held it in 9 quarters.
  • Cubist Systematic Strategies's GeneDx Holdings position peaked at $5.29M in Q3 2024.
  • 225 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.